BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16116476)

  • 1. E2F1 stability is regulated by a novel-PKC/p38beta MAP kinase signaling pathway during keratinocyte differentiation.
    Ivanova IA; D'Souza SJ; Dagnino L
    Oncogene; 2006 Jan; 25(3):430-7. PubMed ID: 16116476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of p38- and CRM1-dependent nuclear export promotes E2F1 degradation during keratinocyte differentiation.
    Ivanova IA; Dagnino L
    Oncogene; 2007 Feb; 26(8):1147-54. PubMed ID: 16924238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation by p38 MAP kinase is required for E2F1 degradation and keratinocyte differentiation.
    Ivanova IA; Nakrieko KA; Dagnino L
    Oncogene; 2009 Jan; 28(1):52-62. PubMed ID: 18794805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor-dependent cyclooxygenase-2 induction in gliomas requires protein kinase C-delta.
    Xu K; Chang CM; Gao H; Shu HK
    Oncogene; 2009 Mar; 28(11):1410-20. PubMed ID: 19169273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2F7 can regulate proliferation, differentiation, and apoptotic responses in human keratinocytes: implications for cutaneous squamous cell carcinoma formation.
    Endo-Munoz L; Dahler A; Teakle N; Rickwood D; Hazar-Rethinam M; Abdul-Jabbar I; Sommerville S; Dickinson I; Kaur P; Paquet-Fifield S; Saunders N
    Cancer Res; 2009 Mar; 69(5):1800-8. PubMed ID: 19223542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERK activation is regulated by E2F1 and is essential for E2F1-induced S phase entry.
    Korotayev K; Chaussepied M; Ginsberg D
    Cell Signal; 2008 Jun; 20(6):1221-6. PubMed ID: 18396012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of extracellular signal-regulated kinase during silibinin-protected, isoproterenol-induced apoptosis in rat cardiac myocytes is tyrosine kinase pathway-mediated and protein kinase C-dependent.
    Zhou B; Wu LJ; Tashiro S; Onodera S; Uchiumi F; Ikejima T
    Acta Pharmacol Sin; 2007 Jun; 28(6):803-10. PubMed ID: 17506939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
    Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
    Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKC pathway and ERK/MAPK pathway are required for induction of cyclin D1 and p21Waf1 during 12-o-tetradecanoylphorbol 13-acetate-induced differentiation of myeloleukemia cells.
    Matsumoto E; Hatanaka M; Bohgaki M; Maeda S
    Kobe J Med Sci; 2006; 52(6):181-94. PubMed ID: 17329956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.
    Cohen EE; Lingen MW; Zhu B; Zhu H; Straza MW; Pierce C; Martin LE; Rosner MR
    Cancer Res; 2006 Jun; 66(12):6296-303. PubMed ID: 16778206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and localization of the activated mitogen-activated protein kinase in lesional psoriatic skin.
    Yu XJ; Li CY; Dai HY; Cai DX; Wang KY; Xu YH; Chen LM; Zhou CL
    Exp Mol Pathol; 2007 Dec; 83(3):413-8. PubMed ID: 17599830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The signalling profile of recombinant human orexin-2 receptor.
    Tang J; Chen J; Ramanjaneya M; Punn A; Conner AC; Randeva HS
    Cell Signal; 2008 Sep; 20(9):1651-61. PubMed ID: 18599270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of senescence in diterpene ester-treated melanoma cells via protein kinase C-dependent hyperactivation of the mitogen-activated protein kinase pathway.
    Cozzi SJ; Parsons PG; Ogbourne SM; Pedley J; Boyle GM
    Cancer Res; 2006 Oct; 66(20):10083-91. PubMed ID: 17047072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of protein kinase C delta activation and STAT3 Ser727 phosphorylation in insulin-induced keratinocyte proliferation.
    Gartsbein M; Alt A; Hashimoto K; Nakajima K; Kuroki T; Tennenbaum T
    J Cell Sci; 2006 Feb; 119(Pt 3):470-81. PubMed ID: 16418226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
    Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
    Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
    Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of human papillomavirus type 31 late promoter activation and genome amplification by protein kinase C.
    Bodily JM; Alam S; Meyers C
    Virology; 2006 May; 348(2):328-40. PubMed ID: 16500689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of epidermal apoptosis and DNA repair by E2F1 in response to ultraviolet B radiation.
    Berton TR; Mitchell DL; Guo R; Johnson DG
    Oncogene; 2005 Apr; 24(15):2449-60. PubMed ID: 15735727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKC isoenzymes differentially modulate the effect of thrombin on MAPK-dependent RPE proliferation.
    Palma-Nicolas JP; López E; López-Colomé AM
    Biosci Rep; 2008 Dec; 28(6):307-17. PubMed ID: 18636965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protein kinase C-eta isoform induces proliferation in glioblastoma cell lines through an ERK/Elk-1 pathway.
    Uht RM; Amos S; Martin PM; Riggan AE; Hussaini IM
    Oncogene; 2007 May; 26(20):2885-93. PubMed ID: 17146445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.